Buying this on the dip - my price target is ~9/share which will give me ~40% profit.
This has been on my list for about a week, just looking for an entry point. If you're able to get in anywhere in the two demand zones (green boxes on the chart - especially at the 5.25 level), I'd say go for it - I am.
Earnings coming up, so be cautious.
About the company: Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.